CYCLERION THERAPEUTICS, INC. Investing Cash Flow
CYCLERION THERAPEUTICS, INC. (CYCN) reported Investing Cash Flow of -$66.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$66.00K.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was $10.40M.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2021 was $1.46M, a 7994.44% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | -$66.00K 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | -$66.00K S-4/A · filed 2026-07-22 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $0.00 S-4/A · filed 2026-07-22 | $0.00 derived: sum of 2 quarters · filed 2026-07-22 | $0.00 derived: sum of 3 quarters · filed 2026-07-22 | |
| 2024-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-K/A · filed 2025-11-12 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $10.40M derived: sum of 2 quarters · filed 2025-11-12 | $10.40M 10-K/A · filed 2025-11-12 | |
| 2023-09-30 | $10.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $10.40M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 10-K · filed 2024-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | -$7.00K derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | -$7.00K derived: sum of 3 quarters · filed 2023-03-22 | -$5.00K derived: sum of 4 quarters · filed 2023-03-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$7.00K derived: sum of 2 quarters · filed 2023-03-22 | -$5.00K derived: sum of 3 quarters · filed 2023-03-22 | $1.46M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$5.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.46M 10-Q · filed 2022-11-03 | $2.89M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.46M 10-Q · filed 2022-08-09 | $2.90M derived: sum of 3 quarters · filed 2022-08-09 | $2.90M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.46M 10-Q · filed 2022-05-04 | $2.90M derived: sum of 2 quarters · filed 2022-05-04 | $2.90M derived: sum of 3 quarters · filed 2022-05-04 | $2.84M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.44M derived: sum of 2 quarters · filed 2022-02-24 | $1.37M derived: sum of 3 quarters · filed 2022-02-24 | $18.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$62.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.42M 10-Q · filed 2021-11-09 | -$1.52M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$1.42M 10-Q · filed 2021-07-29 | -$1.52M derived: sum of 3 quarters · filed 2021-07-29 | -$2.08M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | -$1.36M 10-Q · filed 2021-04-30 | -$1.46M derived: sum of 2 quarters · filed 2021-04-30 | -$2.01M derived: sum of 3 quarters · filed 2021-04-30 | -$6.26M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$654.00K derived: sum of 2 quarters · filed 2021-02-25 | -$4.90M derived: sum of 3 quarters · filed 2021-02-25 | -$6.71M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$4.80M derived: sum of 2 quarters · filed 2020-11-05 | -$6.62M 10-Q · filed 2020-11-05 | -$8.43M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | -$6.06M 10-Q · filed 2020-08-03 | -$7.88M derived: sum of 3 quarters · filed 2020-08-03 | -$9.04M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | -$1.81M 10-Q · filed 2020-05-04 | -$3.63M derived: sum of 2 quarters · filed 2020-05-04 | -$4.79M derived: sum of 3 quarters · filed 2020-05-04 | -$5.09M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$2.98M derived: sum of 2 quarters · filed 2020-03-12 | -$3.28M derived: sum of 3 quarters · filed 2020-03-12 | -$3.44M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.46M derived: sum of 2 quarters · filed 2019-11-12 | -$1.62M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$462.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$162.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |